000			02017 a2200589 4500
005			20250516082347.0
264		0	_c20121130
008			201211s 0 0 eng d
022			_a1872-6968
024	7		_a10.1016/j.clineuro.2012.02.014 _2doi
040			_aNLM _beng _cNLM
100	1		_aKalincik, T
245	0	0	_aInterferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort. _h[electronic resource]
260			_bClinical neurology and neurosurgery _cSep 2012
300			_a940-6 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdjuvants, Immunologic _xadministration & dosage
650	0	4	_aAdolescent
650	0	4	_aAdrenal Cortex Hormones _xtherapeutic use
650	0	4	_aAdult
650	0	4	_aAzathioprine _xtherapeutic use
650	0	4	_aBrain _xpathology
650	0	4	_aCohort Studies
650	0	4	_aDisability Evaluation
650	0	4	_aDisease Progression
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEndpoint Determination
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aInjections, Intramuscular
650	0	4	_aInterferon beta-1a
650	0	4	_aInterferon-beta _xadministration & dosage
650	0	4	_aMagnetic Resonance Imaging
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Sclerosis _xdrug therapy
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aRecurrence
650	0	4	_aTreatment Failure
650	0	4	_aYoung Adult
700	1		_aHorakova, D
700	1		_aDolezal, O
700	1		_aKrasensky, J
700	1		_aVaneckova, M
700	1		_aSeidl, Z
700	1		_aHavrdova, E
773	0		_tClinical neurology and neurosurgery _gvol. 114 _gno. 7 _gp. 940-6
856	4	0	_uhttps://doi.org/10.1016/j.clineuro.2012.02.014 _zAvailable from publisher's website
999			_c21607677 _d21607677